Risperidone modulates the cytokine and chemokine release of dendritic cells and induces TNF-α-directed cell apoptosis in neutrophils

International Immunopharmacology

Volumn 12, Issue 1, 2012, Pages 197-204

  Chen, Mao Liang ^a   Tsai, Tzung Chieh ^b   Wang, Lu Kai ^c   Lin, Yi Yin ^a   Tsai, Ya Min ^a   Lee, Ming Cheng ^a   Tsai, Fu Ming ^a,d  

^a BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

^b NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^c NATIONAL DEFENSE MEDICAL CENTER   (Taiwan)

^d SOOCHOW UNIVERSITY   (Taiwan)

Author keywords

Antipsychotics; Chemokines; Cytokines; Dendritic cells; Risperidone

Indexed keywords

CD4 ANTIGEN; CHEMOKINE; CYTOKINE; GAMMA INTERFERON; GAMMA INTERFERON INDUCIBLE PROTEIN 10; HALOPERIDOL; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 6; INTERLEUKIN 8; RISPERIDONE; TUMOR NECROSIS FACTOR ALPHA;

APOPTOSIS; ARTICLE; CD4+ T LYMPHOCYTE; CELL MATURATION; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXICITY; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE DIFFERENTIATION; MONOCYTE; NEUTROPHIL; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADULT; ANTIPSYCHOTIC AGENTS; APOPTOSIS; CELL DIFFERENTIATION; CYTOKINES; DENDRITIC CELLS; DOPAMINE ANTAGONISTS; HALOPERIDOL; HUMANS; NEUTROPHILS; RISPERIDONE; SEROTONIN ANTAGONISTS; T-LYMPHOCYTES; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84856098970     PISSN: 15675769     EISSN: 18781705     Source Type: Journal    
DOI: 10.1016/j.intimp.2011.11.011     Document Type: Article

References (47)

1. A. Carlsson, and M. Lindqvist Effect of chlorpromazine or haloperidol on formation of 3methoxytyramine and normetanephrine in mouse brain Acta Pharmacol Toxicol (Copenh) 20 1963 140 144
2. J.L. Haracz The dopamine hypothesis: an overview of studies with schizophrenic patients Schizophr Bull 8 3 1982 438 469 (Pubitemid 13233540)
3. J. Tauscher, T. Hussain, O. Agid, N.P. Verhoeff, A.A. Wilson, and S. Houle Equivalent occupancy of dopamine D1 and D2 receptors with clozapine: differentiation from other atypical antipsychotics Am J Psychiatry 161 9 2004 1620 1625 (Pubitemid 39201459)
4. A.A. Megens, F.H. Awouters, A. Schotte, T.F. Meert, C. Dugovic, and C.J. Niemegeers Survey on the pharmacodynamics of the new antipsychotic risperidone Psychopharmacology (Berl) 114 1 1994 9 23 (Pubitemid 24150515)
5. A.B. Erbagci, H. Herken, O. Koyluoglu, N. Yilmaz, and M. Tarakcioglu Serum IL-1beta, sIL-2R, IL-6, IL-8 and TNF-alpha in schizophrenic patients, relation with symptomatology and responsiveness to risperidone treatment Mediators Inflamm 10 3 2001 109 115 (Pubitemid 32735303)
6. X.Y. Zhang, D.F. Zhou, L.Y. Cao, P.Y. Zhang, G.Y. Wu, and Y.C. Shen Changes in serum interleukin-2, -6, and -8 levels before and during treatment with risperidone and haloperidol: relationship to outcome in schizophrenia J Clin Psychiatry 65 7 2004 940 947
7. C.L. Cazzullo, E. Sacchetti, A. Galluzzo, A. Panariello, A. Adorni, and M. Pegoraro Cytokine profiles in schizophrenic patients treated with risperidone: a 3-month follow-up study Prog Neuropsychopharmacol Biol Psychiatry 26 1 2002 33 39 (Pubitemid 34045143)
8. D.J. Kim, W. Kim, S.J. Yoon, H.J. Go, B.M. Choi, and T.Y. Jun Effect of risperidone on serum cytokines Int J Neurosci 111 1-2 2001 11 19 (Pubitemid 34000212)
9. J. Yin, R.H. Albert, A.P. Tretiakova, and B.A. Jameson 5-HT(1B) receptors play a prominent role in the proliferation of T-lymphocytes J Neuroimmunol 181 1-2 2006 68 81 (Pubitemid 44827291)
10. J.C. Ameisen, R. Meade, and P.W. Askenase A new interpretation of the involvement of serotonin in delayed-type hypersensitivity. Serotonin-2 receptor antagonists inhibit contact sensitivity by an effect on T cells J Immunol 142 9 1989 3171 3179 (Pubitemid 19129939)
11. T. Muller, T. Durk, B. Blumenthal, M. Grimm, S. Cicko, and E. Panther 5-hydroxytryptamine modulates migration, cytokine and chemokine release and T-cell priming capacity of dendritic cells in vitro and in vivo PLoS One 4 7 2009 e6453
12. B. Basu, C. Sarkar, D. Chakroborty, S. Ganguly, S. Shome, and P.S. Dasgupta D1 and D2 dopamine receptor-mediated inhibition of activated normal T cell proliferation is lost in jurkat T leukemic cells J Biol Chem 285 35 2010 27026 27032
13. K. Nakano, T. Higashi, R. Takagi, K. Hashimoto, Y. Tanaka, and S. Matsushita Dopamine released by dendritic cells polarizes Th2 differentiation Int Immunol 21 6 2009 645 654
14. M.L. Chen, T.C. Tsai, Y.Y. Lin, Y.M. Tsai, L.K. Wang, and M.C. Lee Antipsychotic drugs suppress the AKT/NF-kappaB pathway and regulate the differentiation of T-cell subsets Immunol Lett 140 1-2 2011 81 91
15. P. Guermonprez, J. Valladeau, L. Zitvogel, C. Thery, and S. Amigorena Antigen presentation and T cell stimulation by dendritic cells Annu Rev Immunol 20 2002 621 667 (Pubitemid 34293436)
16. J. Banchereau, and R.M. Steinman Dendritic cells and the control of immunity Nature 392 6673 1998 245 252 (Pubitemid 28155090)
17. M.B. Lutz, G. Girolomoni, and P. Ricciardi-Castagnoli The role of cytokines in functional regulation and differentiation of dendritic cells Immunobiology 195 4-5 1996 431 455 (Pubitemid 26361475)
18. M.G. Palfreyman, C.J. Schmidt, S.M. Sorensen, M.W. Dudley, J.H. Kehne, and P. Moser Electrophysiological, biochemical and behavioral evidence for 5-HT2 and 5-HT3 mediated control of dopaminergic function Psychopharmacology (Berl) 112 1 Suppl. 1993 S60 S67
19. D.L. Zimbroff, J.M. Kane, C.A. Tamminga, D.G. Daniel, R.J. Mack, and P.J. Wozniak Controlled, dose-response study of sertindole and haloperidol in the treatment of schizophrenia. Sertindole Study Group Am J Psychiatry 154 6 1997 782 791 (Pubitemid 27230100)
20. C. Haslett, L.A. Guthrie, M.M. Kopaniak, R.B. Johnston Jr. , and P.M. Henson Modulation of multiple neutrophil functions by preparative methods or trace concentrations of bacterial lipopolysaccharide Am J Pathol 119 1 1985 101 110 (Pubitemid 15088729)
21. R. Bonecchi, G. Bianchi, P.P. Bordignon, D. D'Ambrosio, R. Lang, and A. Borsatti Differential expression of chemokine receptors and chemotactic responsiveness of type 1 T helper cells (Th1s) and Th2s J Exp Med 187 1 1998 129 134 (Pubitemid 28044828)
22. J.D. Campbell, and K.T. HayGlass T cell chemokine receptor expression in human Th1- and Th2-associated diseases Arch Immunol Ther Exp (Warsz) 48 6 2000 451 456 (Pubitemid 33622200)
23. V. Gangur, F.E. Simons, and K.T. HayGlass IP-10 mediated reinforcement of human type 1 cytokine synthesis to environmental allergens among non-atopic subjects Int Arch Allergy Immunol 118 2-4 1999 387 390 (Pubitemid 29195581)
24. S. Gasperini, M. Marchi, F. Calzetti, C. Laudanna, L. Vicentini, and H. Olsen Gene expression and production of the monokine induced by IFN-gamma (MIG), IFN-inducible T cell alpha chemoattractant (I-TAC), and IFN-gamma-inducible protein-10 (IP-10) chemokines by human neutrophils J Immunol 162 8 1999 4928 4937 (Pubitemid 29314899)
25. A. Sauty, M. Dziejman, R.A. Taha, A.S. Iarossi, K. Neote, and E.A. Garcia-Zepeda The T cell-specific CXC chemokines IP-10, Mig, and I-TAC are expressed by activated human bronchial epithelial cells J Immunol 162 6 1999 3549 3558 (Pubitemid 29313608)
26. Y. Takeda, H. Watanabe, S. Yonehara, T. Yamashita, S. Saito, and F. Sendo Rapid acceleration of neutrophil apoptosis by tumor necrosis factor-alpha Int Immunol 5 6 1993 691 694 (Pubitemid 23209424)
27. M. Riedel, M.J. Schwarz, M. Strassnig, I. Spellmann, A. Muller-Arends, and K. Weber Risperidone plasma levels, clinical response and side-effects Eur Arch Psychiatry Clin Neurosci 255 4 2005 261 268 (Pubitemid 41187035)
28. M.C. Mauri, L.S. Volonteri, A. Colasanti, A. Fiorentini, I.F. De Gaspari, and S.R. Bareggi Clinical pharmacokinetics of atypical antipsychotics: a critical review of the relationship between plasma concentrations and clinical response Clin Pharmacokinet 46 5 2007 359 388 (Pubitemid 46686464)
29. S. Miyamoto, G.E. Duncan, C.E. Marx, and J.A. Lieberman Treatments for schizophrenia: a critical review of pharmacology and mechanisms of action of antipsychotic drugs Mol Psychiatry 10 1 2005 79 104 (Pubitemid 40139590)
30. T. Kaisho, and S. Akira Toll-like receptors as adjuvant receptors Biochim Biophys Acta 1589 1 2002 1 13 (Pubitemid 34242898)
31. J.R. Magliozzi, L.E. Hollister, K.V. Arnold, and G.M. Earle Relationship of serum haloperidol levels to clinical response in schizophrenic patients Am J Psychiatry 138 3 1981 365 367 (Pubitemid 11155889)
32. P.J. O'Connell, X. Wang, M. Leon-Ponte, C. Griffiths, S.C. Pingle, and G.P. Ahern A novel form of immune signaling revealed by transmission of the inflammatory mediator serotonin between dendritic cells and T cells Blood 107 3 2006 1010 1017 (Pubitemid 43156299)
33. P.L. Delgado, D.S. Charney, L.H. Price, G.K. Aghajanian, H. Landis, and G.R. Heninger Serotonin function and the mechanism of antidepressant action. Reversal of antidepressant-induced remission by rapid depletion of plasma tryptophan Arch Gen Psychiatry 47 5 1990 411 418 (Pubitemid 20161259)
34. G.J. Marek, L.L. Carpenter, C.J. McDougle, and L.H. Price Synergistic action of 5-HT2A antagonists and selective serotonin reuptake inhibitors in neuropsychiatric disorders Neuropsychopharmacology 28 2 2003 402 412
35. J.T. Birkett, M.J. Arranz, J. Munro, S. Osbourn, R.W. Kerwin, and D.A. Collier Association analysis of the 5-HT5A gene in depression, psychosis and antipsychotic response Neuroreport 11 9 2000 2017 2020 (Pubitemid 30429155)
36. L.A. Dawson, H.Q. Nguyen, and P. Li The 5-HT(6) receptor antagonist SB-271046 selectively enhances excitatory neurotransmission in the rat frontal cortex and hippocampus Neuropsychopharmacology 25 5 2001 662 668 (Pubitemid 32995948)
37. R. Schreiber, M. Brocco, V. Audinot, A. Gobert, S. Veiga, and M.J. Millan (1-(2,5-dimethoxy-4 iodophenyl)-2-aminopropane)-induced head-twitches in the rat are mediated by 5-hydroxytryptamine (5-HT) 2A receptors: modulation by novel 5-HT2A/2C antagonists, D1 antagonists and 5-HT1A agonists J Pharmacol Exp Ther 273 1 1995 101 112
38. K. Atkin, F. Kendall, D. Gould, H. Freeman, J. Liberman, and D. O'Sullivan Neutropenia and agranulocytosis in patients receiving clozapine in the UK and Ireland Br J Psychiatry 169 4 1996 483 488
39. J.M. Alvir, J.A. Lieberman, A.Z. Safferman, J.L. Schwimmer, and J.A. Schaaf Clozapine-induced agranulocytosis. Incidence and risk factors in the United States N Engl J Med 329 3 1993 162 167 (Pubitemid 23195736)
40. B.J. Kang, M.J. Cho, J.T. Oh, Y. Lee, B.J. Chae, and J. Ko Long-term patient monitoring for clozapine-induced agranulocytosis and neutropenia in Korea: when is it safe to discontinue CPMS? Hum Psychopharmacol 21 6 2006 387 391 (Pubitemid 44355617)
41. B. Finkel, A.G. Lerner, I. Oyffe, and M. Sigal Risperidone-associated agranulocytosis Am J Psychiatry 155 6 1998 855 856
42. Z. Dernovsek, and R. Tavcar Risperidone-induced leucopenia and neutropenia Br J Psychiatry 171 1997 393 394
43. J.A. Lieberman, J. Yunis, E. Egea, R.T. Canoso, J.M. Kane, and E.J. Yunis HLA-B38, DR4, DQw3 and clozapine-induced agranulocytosis in Jewish patients with schizophrenia Arch Gen Psychiatry 47 10 1990 945 948 (Pubitemid 20348482)
44. M. Dettling, R.T. Schaub, B. Mueller-Oerlinghausen, I. Roots, and I. Cascorbi Further evidence of human leukocyte antigen-encoded susceptibility to clozapine-induced agranulocytosis independent of ancestry Pharmacogenetics 11 2 2001 135 141 (Pubitemid 32216124)
45. D. Turbay, J. Lieberman, C.A. Alper, J.C. Delgado, D. Corzo, and J.J. Yunis Tumor necrosis factor constellation polymorphism and clozapine-induced agranulocytosis in two different ethnic groups Blood 89 11 1997 4167 4174 (Pubitemid 27220966)
46. D.P. Williams, M. Pirmohamed, D.J. Naisbitt, J.P. Uetrecht, and B.K. Park Induction of metabolism-dependent and -independent neutrophil apoptosis by clozapine Mol Pharmacol 58 1 2000 207 216 (Pubitemid 30452544)
47. D.P. Williams, M. Pirmohamed, D.J. Naisbitt, J.L. Maggs, and B.K. Park Neutrophil cytotoxicity of the chemically reactive metabolite(s) of clozapine: possible role in agranulocytosis J Pharmacol Exp Ther 283 3 1997 1375 1382 (Pubitemid 28016513)